Microbial and viral infections of the brain and spinal cord result in inflammation that underlies wide ranging symptoms including fever, headache, confusion, and in extreme cases, stroke, seizure, or even death. The resulting disease is classified based on the area of the central nervous system (CNS) affected and can include the membranes that surround the brain (meningitis), spinal cord (myelitis), or inflammation within the brain parenchyma (encephalitis). Of these, encephalitis tends to be associated with more significant alterations in the level of consciousness, cognitive defects, seizures, and focal neurological deficits than meningitis, although it should be noted that clinical presentation of these conditions often overlap. The incidence of encephalitis in the United States has been estimated at approximately 20,000 new cases annually according to the Centers for Disease Control (CDC). While encephalitis and meningitis can be caused by bacterial or fungal pathogens, viruses are the major causative agents of CNS infection worldwide, with an overall incidence of 6.34 per 100,000 for all ages ([@B43]). However, it must be noted that this number is likely to be an underestimation given the problems associated with diagnosis, particularly in developing countries ([@B87]).

Viral CNS infections can be very difficult to treat due to the rapid onset of severe disease symptoms that can occur even in otherwise healthy individuals. Such infections trigger broad activation of glial cells including microglia and astrocytes, and the concomitant release of an array of pro-inflammatory molecules that can elicit both innate and adaptive immune responses. While host responses limit viral replication and dissemination and can lead to infection resolution, overzealous, or sustained inflammation within the CNS can result in significant neurological damage.

One of the major challenges in the study and treatment of viral CNS infections is the wide range of etiological agents ([@B104]). Both RNA and DNA viruses can infect the CNS and cause meningitis or encephalitis, although an etiological diagnosis is established in less than 30% of cases ([@B90]). While historically important RNA viruses that can cause encephalitis such as measles, mumps, and rubella have seen steep decreases in incidence as a result of immunization ([@B52]), rabies virus (RABV) remains an endemic cause of viral encephalitis in the United States and a serious public health concern. RABV is transmitted from animals to humans and although rare, CNS infection results in uncontrolled virus replication, a prominent pro-inflammatory response, and is 100% fatal once neurological symptoms develop ([@B101]).

In addition, emerging RNA viral pathogens such as West Nile virus (WNV; [@B29]), Japanese encephalitis virus (JEV), Australian bat Lyssavirus ([@B81]), retroviruses, and Nipah virus ([@B65]) have become increasingly important causes of encephalitis. Nipah virus was first identified in 1999 and the mortality rate associated with acute encephalitis caused by this virus has been estimated to be between 40 and 75% (as reviewed in [@B105]). While most survivors make a full recovery, 20% demonstrate neurological sequelae and a small number develop delayed-onset encephalitis.

Worldwide, the flavivirus JEV is the most common cause of arthropod-borne encephalitis with over 50,000 cases reported per year in China, Southeast Asia, and India ([@B112]). Epidemics due to this arbovirus result in a mortality rate that ranges from 30 to 50% with death usually occurring within the first week ([@B77]; [@B89]), and the development of sustained neurological deficits in approximately half of the survivors ([@B26]). Another flavivirus, WNV, is also transmitted by *Culex* spp. mosquitoes and can cause fatal encephalitis or long-term neurological sequelae. Once inside the CNS, JEV, and WNV infect neurons ([@B107]; [@B88]; [@B51]) leading to neuronal apoptosis ([@B58]; [@B71]) and causing severe immunopathology ([@B59]). WNV has been associated with over 12,000 cases of encephalitis and/or meningitis in the U.S. with a mortality rate of 9.5% as reported by the CDC.

DNA viral agents that can infect the CNS include varicella zoster virus (VZV) and several viruses in the human herpesvirus family that can cause encephalitis, including human herpesvirus 6 ([@B38]), herpes simplex virus 1 (HSV-1), and HSV-2 ([@B4]). VZV is a medically important cause of encephalitis characterized by up to 25% mortality and rates close to 100% in immunocompromised patients ([@B90]). However, HSV is considered to be an endemic cause of encephalitis in the United States and is the most frequent cause of this disease in adults ([@B90]) while HSV-2 is the most significant etiological agent of severe encephalitis in children ([@B77]; [@B7]). Neonatal HSV-2 encephalitis, with treatment, has a mortality rate of 14% (compared to 85% without treatment) and severe neurological dysfunction is observed in 50--70% of surviving individuals. HSV-1 encephalitis in older children represents the most common cause of sporadic fatal viral encephalitis ([@B4]). Untreated patients with HSV-1 encephalitis have a 70% mortality rate, while patients who receive early treatment have a 40% chance of recovering without neurological deficits. However, despite appropriate diagnosis and therapy, the mortality rate remains at 30% ([@B114]; [@B4]). HSV encephalitis may follow primary infection but most cases are the due to the reactivation of latent virus in the olfactory bulb or trigeminal ganglia and subsequent retrograde axonal transport into the CNS (as reviewed in [@B17]).

The complexity seen in viral encephalitis due to the array of causative agents, clinical presentations, and severity has made defining the mechanisms that underlie disease pathology challenging. Ideally, host responses following CNS infection should result in rapid neutralization of the invading pathogen with minimal collateral damage to the sensitive and poorly regenerating neural tissue. However, viral CNS infections are often associated with inadequate anti-viral responses and/or the rapid and severe onset of damaging inflammation (as reviewed in [@B83]). While the brain has traditionally been viewed as a "victim organ" of infiltrating leukocytes, it has become apparent that specialized resident glial cells, such as microglia and astrocytes, play an essential role in regulating the permeability of the blood--brain barrier, promoting the recruitment of leukocytes, and the activation of such cells following infiltration.

GLIAL CELLS PLAY A CRITICAL ROLE IN THE INITIATION OF VIRALLY INDUCED NEUROINFLAMMATION
=======================================================================================

Microglia and astrocytes are well known to play an important role in homeostasis within the CNS and to support neuronal cell function. However, these cell types are now recognized to be key players in the development of protective immune responses or the progression of damaging inflammation during CNS disease states ([@B5]; [@B92]; [@B20]; [@B22]). Microglia are resident myeloid immune cells of the CNS and, similar to other myeloid cells such as macrophages and dendritic cells, these cells are facultative phagocytes and express antigen presenting MHC class II molecules ([@B34]). Importantly, microglia produce key pro-inflammatory mediators such as IL-1β ([@B64]), TNF-α ([@B93]), IL-6 ([@B49]), and bioactive IL-12 p70 ([@B2]; [@B96]) following activation. Astrocytes are the major glial cell type in the brain and may also function as immune effector cells ([@B20]). Stimulated astrocytes can express an array of inflammatory cytokines and chemokines that can initiate leukocyte migration across the blood--brain barrier and promote effector functions in these infiltrating cells ([@B20]). As such, these cells are ideally situated to detect and respond to invading pathogens including neurotropic viruses.

Viral infections in the CNS are known to broadly trigger glial activation and the release of pro-inflammatory molecules. For example, it is known that pro-inflammatory cytokines, IFN-γ and TNF-α, are markedly increased in CNS tissues during HSV-1 infection in the brain and microglia have been shown to respond to HSV-1 by secreting pro-inflammatory and chemotactic molecules such as TNF-α, IL-1β, IL-6, IL-12, CCL7, CCL8, CCL9, CXCL1, CXCL2, CXCL4, and CXCL5 ([@B61]; [@B3]). Human microglia have also been shown to respond to RNA viruses including WNV by producing cytokines and chemokines ([@B15]). Elevated levels of IL-1β are readily detectable in neural tissue from WNV encephalitis patients and cultured human glia produce this potent inflammatory cytokine in response to WNV challenge ([@B106]). We have also documented the ability of primary cultured microglia and astrocytes to respond to several RNA and DNA viruses, including vesicular stomatitis virus (VSV), Sendai virus, murine gammaherpesvirus (MHV)-68, and HSV-1, by producing inflammatory mediators such as IL-6, TNF-α, and IL-1β ([@B74]; [@B14]; [@B25], [@B23]). Importantly, we confirmed that *in vivo* VSV administration results in viral infection of both glial cell types *in situ*, while earlier studies demonstrated that microglia and astrocytes respond to VSV by proliferating, producing inducible nitric oxide synthase, and increasing the expression of cell surface MHC class II molecules ([@B6]), responses that are likely to set the stage for subsequent inflammatory damage.

An immune response to a virus in the CNS requires the recognition of this pathogen and the mechanisms by which innate immune cells achieve this have only recently become apparent with the discovery of a variety of cell surface and cytosolic molecules that serve as sensors for viral components. Such pattern recognition receptors (PRRs) are present on and within immune sentinel cells ([@B24], [@B23]; [@B50]) and appear to bind conserved viral structures known as pathogen-associated molecular patterns (PAMPs). These PAMPs have several features that make them ideal targets for innate immune recognition. First, PAMPs are unique to microbes and viruses allowing for "self" versus "non-self" recognition by the innate immune system. Second, PAMPs are often conserved among similar pathogens allowing a relatively small number of PRRs to detect a broad array of challenges. In addition, PAMPs tend to be essential for microbial/viral survival making pathogen evasion by genetic mutation or deletion unlikely ([@B68]).

Pattern recognition receptor engagement by PAMPs can precipitate the production of anti-viral type I interferons (IFN) and/or the release of chemotactic and inflammatory molecules that can then direct a subsequent adaptive immune response. Three families of PRRs have been defined: Toll-like receptors (TLRs), nucleotide oligomerization domain (NOD)-like receptors (NLRs), and retinoic acid inducible gene (RIG)-I-like receptors (RLRs). As such, these molecules represent important mechanisms by which a protective host response or potentially damaging inflammation is initiated ([@B47]; [@B115]).

TLRs MEDIATE GLIAL RESPONSES TO EXTRA CELLULAR OR ENDOSOMAL VIRAL MOTIFS
========================================================================

*Toll* was first identified as a gene critical for fruit fly embryogenesis ([@B32]) but its products were subsequently shown to play an important role in *Drosophila*'s immunity to fungal infections ([@B55]). Interestingly, similar gene products were found in mammalian cells and these TLRs have since been shown to play an important role in the initiation of innate immune responses to infection ([@B69]). To date, at least 13 TLRs have been discovered in mammals and members of this family of cell surface receptors can elicit inflammatory and/or anti-viral mediator production and can serve to initiate or modify adaptive immune responses (as reviewed in [@B48]). Acute virally induced CNS inflammatory responses occur within the first few days following infection and this argues against a central role for activated T cell clones in such responses. Indeed, previous studies have shown that acute viral encephalitis can occur in athymic mice ([@B6]). That being said, T cell subpopulations, such as Th1 and Th17 cells, are almost certain to play a key role in sustained virally induced neuroinflammation ([@B45]). As such, glial activation via TLRs and other PRRs is likely to facilitate antigen presentation to, and costimulation of, such cells and the role of these receptors in the antigen-specific activation of T cells following viral challenge has been extensively reviewed elsewhere ([@B48]).

Several TLRs have been demonstrated to specifically recognize viral motifs, including TLRs 2, 3, 7, 8, and 9. While TLR2 is best known to bind a variety of microbial cell wall component including lipoproteins, peptidoglycans, and lipoteichoic acid present in bacterial cell walls and the yeast cell wall component zymosan, this sensor can also recognize as yet unidentified viral motifs. In contrast, endosomal TLRs such as TLR3 recognize viral double-stranded RNA (dsRNA) and its synthetic analog, polyinosine-deoxycytidylic acid (poly(I:C)), while TLR7 and TLR8 mediate responses to GU-rich single-stranded RNA (ssRNA) produced in virus-infected cells. Finally, TLR9 detects bacterial and viral DNA with unmethylated CpG motifs. Studies from our group and others have demonstrated that microglia and astrocytes constitutively express low levels of TLR3 ([@B42]; [@B9]), TLR7 ([@B42]), and TLR9 ([@B8]; [@B42]), but such expression shows marked upregulation following viral infection and/or stimulation with viral components ([@B8]; [@B11]; [@B42]; [@B67]; [@B66]; [@B9]). While these findings suggest that glial cells could become sensitized to the presence of viral pathogens, it is presently unclear whether sustained stimulation via these sensors can alter the pattern of immune mediator production by glial cells to one that favors the resolution of inflammation.

Upon ligand binding, TLRs dimerize and undergo conformational changes precipitating a complex cascade of intracellular signaling events that ultimately result in activation of transcription factors including nuclear factor-κB (NF-κB), and interferon-regulatory factors (IRF) 3 and 7 (as reviewed in [@B48]; [@B113]). NF-κB is a critical transcription factor in the regulation of inflammatory cytokine production, while IRF-3 and IRF-7 activation stimulates expression of anti-viral genes including IFN-β. Hence, activation of cells via these receptors can initiate the repertoire of defense mechanisms used by the innate immune system against viral pathogens.

TLR3 is perhaps the most widely studied PRR in the perception of viral pathogens by glial cells. Isolated murine wild-type microglia are known to respond to the TLR3 ligand poly(I:C) by secreting TNF-α and IL-6 ([@B70]). In line with these findings, intracerebral administration of poly(I:C) has been shown to elicit microglial ([@B70]; [@B102]) and astrocyte ([@B70]) activation associated with neuronal loss, a response that is nearly absent in TLR3 knockout animals ([@B102]). Circumstantial evidence for the involvement of TLR3 in viral encephalitis comes from the finding that the expression of this PRR is upregulated following RABV infection prior to the onset of lethal neuroinflammation ([@B67]; [@B66]).

Several studies have implicated TLR3 activation in WNV-associated pathogenicity. dsRNA, a ligand for TLR3, is produced by WNV during infection and has been shown to trigger the release of cytokines and chemokines from human microglia ([@B15]). Seemingly in keeping with these observations, TLR3 deficient mice were found to be resistant to lethal WNV-associated encephalitis. The fulminate CNS inflammatory response seen in wild-type mice, characterized in part by activated microglia, was markedly reduced or absent in knockout animals following intraperitoneal WNV infection ([@B109]). However, this reduced CNS disease occurs despite increased peripheral viral loads and reduced systemic production of anti-viral and pro-inflammatory cytokines ([@B110]). These results suggest that decreased systemic inflammation in the absence of TLR3 expression may maintain blood--brain barrier integrity and prevent WNV access into the CNS ([@B110]). Such a hypothesis is supported by the demonstration that direct intracerebral administration of WNV leads to identical outcomes in wild-type and TLR3 deficient mice ([@B110]). However, it must be noted that at least one study appears to contradict this finding in that neuronal WNV replication was increased in TLR3 knockout animals following subcutaneous infection and the reason for this apparent disparity is presently unclear ([@B18]).

Another endosome-associated PRR, TLR7, also appears to play an important role in inflammatory and/or protective glial responses to viral pathogens. Intracerebral administration of the TLR7 agonist imiquimod leads to pronounced neuroinflammation, with upregulated expression of TNF-α, IL-1α, IL-1β, IL-6, and IL-12 as well as the chemokines CCL2, CCL3, CXCL1, CXCL9, and CXCL10 ([@B10]). Interestingly however, this effect appears to be predominantly due to the activation of astrocytes rather than microglia ([@B10]). Upregulation of TLR7 has been demonstrated in the brains of infected mice prior to lethal RABV-induced inflammation ([@B66]). Furthermore, mice lacking the expression of MyD88, a critical downstream effector molecule of TLRs including TLR7, have increased susceptibility to an attenuated RABV strain and TLR7 deficient mice exhibited a phenotype with deficits in both the development of peripheral immunity and RABV clearance from the CNS ([@B56]). As such, these data indicate a possible role for TLR7 in viral clearance from infected brain tissue. In contrast, another report has shown that macrophages isolated from TLR7 deficient animals released less IL-12 and IL-23 in response to *in vitro* WNV infection and TLR7 knockout mice demonstrated an increased susceptibility to WNV encephalitis ([@B103]).

It has recently been shown that TLR2 contributes to detrimental inflammatory cytokine production in mice following intracranial administration with HSV-1, with the absence of TLR2 expression leading to decreased peripheral ([@B54]) and CNS ([@B3]) inflammatory response sand increased survival. In addition, multiple reports have shown that maximal *in vitro* microglial and astrocyte responses to HSV-1 are dependent on the presence of TLR2 ([@B61]; [@B3]; [@B84]; [@B108]) and HSV-1-infected microglia derived from TLR2 deficient mice have been demonstrated to elicit less neuronal oxidative damage and death in mixed neural cell cultures in comparison to infected wild-type microglia ([@B84]). However, it should be noted that these studies differ in their assessments of the relative importance of this PRR in such responses, and marked elevations in serum IL-6 concentrations have been found in TLR2 deficient mice following HSV-1 infection ([@B54]). Together, these data suggest while TLR2 may play a major role in HSV-induced pathology and mortality, additional mechanism(s) are likely to be involved.

In addition to the detection of HSV virion motifs by TLR2, genomic HSV DNA can be recognized by TLR9 and at least one study suggests that this sensor might play a more significant role in lethal HSV-1 encephalitis than TLR2 ([@B60]). In contrast, others have shown that the absence of TLR9 alone does not impact survival, type I IFN levels, or viral replication in the brain following HSV infection ([@B108]). Since TLR2/9 double knockout mice show significantly greater susceptibility to HSV-1 infection than mice deficient in either TLR2 or TLR9 alone ([@B60]), it appears likely that these sensors act in a cooperative or synergistic manner.

Taken together, this body of work suggests that TLR activation is a significant contributor to sustained glial activation, inflammatory mediator production, and neuronal loss during viral CNS infections. However, it is important to note that TLRs can also mediate beneficial effects. For example, the activation of glial cells via TLR2, 3, or 9 has been shown to initiate the production of type I IFNs ([@B120]; [@B17]) which limit viral replication through the induction of proteins such as RNase L and IFN-induced dsRNA-activated protein kinase, resulting in mRNA degradation and cessation of translation, respectively ([@B82]). Furthermore, two recent studies ([@B119]; [@B30]) indicate that a genetic deficiency in TLR3 expression can predispose children to HSV-1 encephalitis and implicate a key role for this PRR in protective CNS immune responses against this, but not other, pathogens. However, the mechanisms that keep the balance between damaging and protective glial responses have not been identified and are likely to include a multitude of variables including the number of infectious organisms, the kinetics of glial activation and immune mediator production, the specific identity of the responsive glial cell, and the direct influence of the pathogen itself on the cellular response. Moreover, evidence is accumulating that TLR expression is not limited to glial cells and that neurons can also express such PRRs under certain conditions (as reviewed in [@B13]), although, the functional relevance of TLR expression in neurons has not been resolved.

While cell-surface receptors like TLRs appear to play an important role in glial responses to extracellular pathogens or those present in intracellular compartments, the ability of such cells to respond to pathogens in the absence of TLR expression suggests that additional mechanisms are present. Furthermore, our recent studies employing the model neurotropic RNA virus, VSV, demonstrate that viral replication is required to elicit robust immune responses by infected microglia and astrocytes, and indicate that mechanisms exist to sense the presence of replicative viral products within infected cells. We have shown that heat inactivated wild-type VSV or a host-range limited VSV mutant ([@B28]) elicit glial immune responses that are an order of magnitude smaller than those induced by wild-type viral particles ([@B14]). These results suggest that VSV-induced glial responses are not predominantly mediated by cell surface and/or endosomal PRRs and indicate that active viral replication is a critical requirement for such responses.

The recent demonstration that microglia and astrocytes express members of the newly described RLR family of PRRs may provide a mechanism underlying the replication-dependent nature of glial responses ([@B24]). RLRs such as RIG-I and melanoma differentiation-associated gene 5 (MDA5) have been shown to serve as intracellular PRRs for viral nucleic acid motifs ([@B46]; [@B99]), and their involvement in inflammatory and anti-viral responses in other cell types raises the intriguing possibility that these cytosolic sensors could play an important role in glial responses to viral infection.

RIG-LIKE RECEPTORS CAN MEDIATE PROTECTIVE IMMUNE RESPONSES AND DAMAGING CNS INFLAMMATION FOLLOWING RNA VIRUS INFECTION
======================================================================================================================

In contrast to cell-surface TLRs, RLRs detect viral RNA motifs or processed self-RNA in the cytoplasm to trigger innate immunity and inflammation ([@B100]). These intracellular sensors are responsible for the production of type I IFNs in most cell types in response to RNA virus infection ([@B94]; [@B46]; [@B80]; [@B63]). In addition to such anti-viral responses, RLR engagement also elicits robust inflammatory cytokine production ([@B100]). As shown in **Figure [1](#F1){ref-type="fig"}**, helicase interaction with viral RNA induces the recruitment of downstream effector molecules including interferon promoter stimulator (IPS)-1 (also known as VISA, Cardif, or MAVS), TNF receptor associated factor (TRAF) 3 ([@B100]), and perhaps stimulator of interferon genes (STING; [@B40]), leading to the activation of mitogen activated protein (MAP) kinases, and the IκB kinase (IKK)-related kinases, TRAF family member-associated NF-κB activator (TANK) binding kinase 1 and IKK-I. These kinases activate the transcription factors NF-κB and IRF-3, which translocate into the nucleus and activate transcription of IFN stimulated genes and inflammatory cytokines. RLRs are comprised of three domains: N-terminal caspase activation and recruitment domains (CARDs), a helicase domain, and a C-terminal domain (CTD). Although RIG-I and MDA5 show structural homology ([@B117]) and share signaling features ([@B116]), it is now known that the two helicases discriminate between differing ligands to trigger innate immune responses to RNA viruses.

![**Retinoic acid inducible gene (RIG)-I-like receptors serve as cytosolic sensors for viral RNA motifs and can initiate anti-viral and inflammatory cell responses.** Melanoma differentiation-associated gene 5 (MDA5) recognizes double-stranded RNA moieties (dsRNA), while RIG-I perceives short single or double-stranded RNAs with 5' triphosphate ends (ppp-ssRNA). Helicase interaction with these viral RNAs induces the recruitment of downstream effector molecules including mitochondrial- or peroxisomal-associated interferon promoter stimulator (IPS)-1, TNF receptor associated factor (TRAF) 3, and/or stimulator of interferon genes (STING), leading to the activation of IκB kinase (IKK)-related kinases, TRAF family member-associated NF-κB activator binding kinase 1 (TBK1), and IKK-I. These kinases activate the transcription factors NF-κB and interferon-regulatory factors (IRF) 3, which translocate into the nucleus and activate transcription of anti-viral and inflammatory cytokines.](fmicb-03-00201-g001){#F1}

Signaling by RIG-I is triggered during infection by a number of RNA viruses and by the presence of synthetic RNA transcribed *in vitro* ([@B94]; [@B46]; [@B80]; [@B63]; [@B76]). It appears that RIG-I recognizes ssRNA or dsRNA moieties with 5′ triphosphate ends (5′ppp-ssRNA and 5′ppp-dsRNA, respectively; [@B36]; [@B72]) or RNAs that assume complex secondary structures ([@B94]; [@B80]). More recent studies have elucidated the structural basis underlying RIG-I activation. Inactive RIG-I has an open conformation in which the CARD domains are sequestered by a helical domain inserted between the helicase moieties. When activated, ATP and RNA binding induce a major rearrangement in RIG-I to a closed conformation in which the helicase and the CTD bind to the blunt end 5′ppp-dsRNA with perfect complementarity ([@B53]).

In contrast, MDA5 has been reported to be more selective and is triggered during picornavirus infections or in the presence of poly(I:C) ([@B27]; [@B46]; [@B62]). The CTD domains of MDA5 and RIG-I involved in RNA binding have been suggested to be responsible for the differences in ligand affinity seen between these RLRs. Each have a similar fold and basic surface but distinct RNA binding loops exist within the CTD for RIG-I and MDA5, and the conformation of this RNA binding loop seems to be responsible for sensitivity to dsRNA or 5′ppp-ssRNA. Such a conclusion is supported by RLR structural analysis and studies featuring mutation of the basic surface and the RNA binding loop ([@B57]; [@B97]).

We have recently demonstrated that expression of both RIG-I and MDA5 is discernable in uninfected mouse brain tissue ([@B24]). Importantly, we have shown that isolated murine microglia and astrocytes constitutively express RIG-I and MDA5 transcripts and protein, as well as the critical downstream effector molecule, IPS-1 ([@B24]). Furthermore, the expression of these novel viral sensors has been confirmed in human glial cells ([@B118]; [@B25]). Circumstantial evidence of a role for these RLRs in RNA virus infections of the CNS comes from our observation that RIG-I and MDA5 expression is elevated in the brains of mice following intranasal administration of VSV ([@B24]). VSV is a neurotropic negative-sense ssRNA virus that closely resembles RABV. In mice, intranasal VSV infection results in a severe encephalitis with rapid activation and proliferation of microglia and astrocytes ([@B37]; [@B6]) and our *in vitro* studies show that this virus elicits marked increases in RIG-I expression by murine and human glial cells ([@B24], [@B25]).

More direct evidence for the functional nature of RIG-I expression in glia comes from our observation that this molecule associates with IPS-1 following VSV infection and from the finding that the specific RIG-I ligand, 5′ppp-ssRNA, elicits human astrocyte immune responses ([@B25]). Importantly, we also showed that RIG-I knockdown significantly reduces inflammatory cytokine production by VSV-infected human astrocytes and inhibits the production of soluble neurotoxic mediators by virally challenged cells ([@B25]). These findings directly implicate RIG-I in the initiation of glial inflammatory immune responses and suggest a potential mechanism underlying the neuronal cell death associated with acute viral CNS infections.

In contrast to the proposed detrimental role for RLR activation following challenge with VSV, other work suggests that IPS-1 is essential for triggering protective innate and adaptive immunity against WNV in the CNS. In these studies, mice deficient in the RLR adaptor molecule IPS-1 exhibited increased susceptibility to WNV infection, characterized by enhanced inflammation, viral replication, and rapid dissemination into the CNS ([@B95]). However, it is important to note that glial cells were not the focus of this study and IPS-1 dependent IFN responses and limiting of viral replication was attributed to effects on systemically generated immune cells and cortical neurons, perhaps via changes in the numbers and/or function of regulatory T cells ([@B95]). As such, these data suggest an innate/adaptive immune interface mediated through RLR signaling that regulates the balance of the immune response to WNV infection. Together, these findings raise the exciting possibility that RLR molecules play important roles in the detection of viral CNS pathogens and, depending upon the host cell type and viral pathogen, the initiation of protective immune responses or damaging inflammation within the brain.

NEWLY DISCOVERED CYTOSOLIC VIRAL SENSORS MAY MEDIATE GLIAL RESPONSES TO DNA VIRUSES
===================================================================================

Recently, novel cytosolic DNA sensors have been discovered that include DNA-dependent activator of interferon-regulatory factors (DAI; also known as Z-DNA binding protein 1; [@B98]) and a DNA-sensing inflammasome consisting of the HIN200 protein, absent in melanoma 2 (AIM2; [@B85]). Acting in concert with TLRs, these receptors may provide a diverse repertoire of mechanisms to alert the cell to viral and microbial DNA, leading to the activation of the innate immune system in a similar manner to that seen with RLR-mediated responses to viral RNA. DAI reportedly senses cytosolic DNA using two N-terminal Z-DNA binding domains (ZBDs) and a third putative DNA binding domain located next to the second ZBD. Analysis of the DAI/Z-DNA complex structure reveals that DAI adopts an unusual binding mode for Z-DNA recognition ([@B31]). The DAI ZBDs bind DNA and both must be bound for full B-to-Z conversion, and so it is conceivable that the binding of two DAI proteins to each cytoplasmic dsDNA elicits DAI dimerization and subsequent innate immune activation ([@B31]; [@B111]).

Importantly, DAI has been shown to recognize double-stranded DNA in its canonical B helical form (B-DNA; [@B98]) and elicit type I IFN and inflammatory cytokine production in a TLR9-independent manner ([@B39]; [@B91]) in other cells types. As shown in **Figure [2](#F2){ref-type="fig"}**, DAI elicits such immune functions via activation of the IRF and NF-κB transcription factors. DAI-induced IRF activation is dependent upon TANK-binding kinase 1 (TBK1). In contrast, DAI-induced NF-κB activation is mediated through interactions between two receptor-interacting protein (RIP) homotypic interaction motifs (RHIMs) in the DAI protein and RHIM-containing kinases, RIP1 and RIP3 ([@B44]; [@B75]), as shown by the demonstration that knockdown of either RIP1 or RIP3 inhibits DAI-induced NF-κB activation. Both of these activation pathways appear to be induced via the recruitment of the adaptor molecules IPS-1, TRAF3, and STING. The importance of these adaptor molecules in host immune responses to DNA viruses is exemplified by the demonstration that the loss of STING renders mice susceptible to lethal HSV-1 infection ([@B40]).

![**DNA-dependent activator of IFN regulatory factors (DAI) can serve as a cytosolic sensor for viral or microbial double-stranded DNA (dsDNA) motifs and initiate anti-viral and inflammatory cell responses.** DAI elicits such immune functions via possible interactions with mitochondrial- or peroxisomal-associated interferon promoter stimulator (IPS)-1, and/or stimulator of interferon genes (STING), facilitating the activation of the interferon-regulatory factors (IRF) and NF-κB transcription factors. DAI-induced IRF activation is dependent on TANK-binding kinase 1 (TBK1). In contrast, DAI-induced NF-κB activation is mediated through interactions involving receptor-interacting protein (RIP) 1 and RIP3 kinases.](fmicb-03-00201-g002){#F2}

Overexpression of DAI in mouse fibroblasts enhances DNA-mediated type I IFN production while DAI knockdown attenuates responses to viral DNA ([@B98]). In an additional study, DNA-mediated activation of NF-κB and the induction of NF-κB-dependent genes and their products were also significantly inhibited in cells following DAI knockdown ([@B75]). As such, these data are suggestive of a significant role for DAI in DNA-mediated activation of the NF-κB pathway and viral recognition. However, it is interesting to note that DAI-mediated NF-κB activation appears to facilitate HIV-1 replication although the mechanisms underlying this effect remain unclear ([@B33]).

DAI is reported to be expressed in the lymph nodes and spleen constitutively, but detectable levels are also found in circulating leukocytes and other tissues including bone marrow and small intestines ([@B78]). In the CNS, we have shown that microglia and astrocytes constitutively express DAI and its effector molecules RIP3 and STING, and show that such expression is upregulated following DNA virus challenge ([@B23]). *In vivo* HSV-1 infection elicited an upregulation in microglial DAI expression by up to 23.8-fold over that seen in resting cells, and despite strong constitutive expression, HSV-1 exposure was also able to further increase DAI expression in astrocytes with a maximal increase of 2.2-fold over that seen in unstimulated cells. Interestingly, the ability of viral challenge to augment DAI expression by primary glial cells was not limited to this neurotropic alpha herpesvirus, as the lymphotropic gammaherpesvirus, MHV-68, was also capable of eliciting robust increases in microglial DAI expression and caused modest increases in the expression of this molecule in astrocytes.

Importantly, we showed that transfection with the DAI specific ligand B-DNA elicits inflammatory cytokine production by isolated glial cells, with induced production of the inflammatory cytokines TNF-α and IL-6 as rapidly as 6 h post-transfection at levels that matched or exceeded those elicited following a 24-h HSV-1 challenge ([@B23]). To confirm the functional status of DAI in glial cells and to begin to determine the relative importance of this innate immune sensor in their responses to neurotropic DNA viruses, we also assessed the effect of DAI knockdown on inflammatory cytokine production by HSV-1 challenged microglia and astrocytes ([@B23]). We found that siRNA directed against DAI significantly attenuated HSV-1 induced TNF-α and IL-6 production by murine microglia. Such an approach also markedly reduced IL-6 release by HSV-1 infected astrocytes but was not as effective in reducing TNF-α expression by these cells, where a statistically significant reduction was only observed at the highest viral MOI used ([@B23]). Finally, we demonstrated that HSV-1 challenged microglia and astrocytes release neurotoxic mediators and showed that such production is significantly attenuated following DAI knockdown ([@B23]).

As such, the functional expression of DAI by microglia and astrocytes may represent an important innate immune mechanism underlying the rapid and potentially lethal inflammation associated with neurotropic DNA virus infection. However, the involvement of DNA sensor(s) other than DAI cannot be excluded. For example, a new DNA sensor, AIM2, has been identified which binds to DNA (as reviewed in [@B73]). Upon DNA ligation, AIM2 associates with the apoptosis-associated speck-like protein containing a CARD (ASC) leading to NF-κB and caspase-1 activation and inflammatory cytokine production. AIM2 knockdown has been shown to reduce such inflammasome formation and caspase-1 activation in response to dsDNA administration and infection with vaccinia virus ([@B35]) and stable transfection of cell-lines with AIM2 has been demonstrated to confer responsiveness to cytoplasmic DNA ([@B21]). To date, the role of AIM2 in innate immune responses to DNA viruses in the CNS has not been explored.

PRRs ACT IN A COOPERATIVE MANNER TO INDUCE GLIAL RESPONSES TO VIRAL CHALLENGES
==============================================================================

While the preceding sections have focused on the roles of specific individual PRRs in the detection of viral pathogens by CNS cells, it is highly likely that glial responses represent the sum of the inputs from disparate cell surface, endosomal, and cytosolic viral sensors (as shown in **Figure [3](#F3){ref-type="fig"}**). We, and others, have demonstrated that the level of expression of a particular TLR, NLR, or RLR by microglia and astrocytes can be regulated by ligands for dissimilar PRRs ([@B8]; [@B42]; [@B12]). Furthermore, mechanisms of positive and negative regulation of RLR signaling have been identified that include signaling cross-talk between RLR, NLR and DNA-sensing pathways, and caspase networks. For example, it has been shown that mice deficient in the expression of the DAI downstream effector molecule STING are highly susceptible to infection by negative-stranded viruses including VSV suggesting a role for this signaling molecule in both DAI and RIG-I mediated cell activation ([@B40]). Immunoprecipitation studies indicate STING associates with RIG-I complexes in close proximity to endoplasmic reticulum associated mitochondria ([@B41]; [@B19]). Interestingly, a number of RNA viruses including yellow fever virus, dengue virus, and hepatitis C virus, encode proteins with significant structural homology to STING and at least one of these proteins produced by the dengue virus has been shown to inhibit STING function ([@B41]). As such, these observations suggest a role for STING in anti-viral host responses to both DNA and RNA viruses.

![**Possible interactions between Toll-like receptors (TLRs; e.g., TLR3 and TLR7/8), nucleotide oligomerization domain (NOD)-like receptors (NLRs; e.g., NOD2), retinoic acid inducible gene (RIG)-I-like receptors (RLRs; e.g., RIG-I and MDA5) and DNA-dependent activator of IFN regulatory factors (DAI) in the detection of viruses and the initiation of glial immune responses.** These disparate cell surface, endosomal, and cytosolic sensors share common signaling components including interferon promoter stimulator (IPS)-1 and stimulator of interferon genes (STING), leading to the activation of the transcription factors NF-κB and interferon-regulatory factor (IRF) 3, which translocate into the nucleus and initiate anti-viral and inflammatory cytokine production. In addition, the activity of RNA polymerase III (Pol III) could provide an additional mechanism for the perception of DNA viruses via RLRs.](fmicb-03-00201-g003){#F3}

Another example of cross-talk between viral sensing pathways is the recent demonstration that RIG-I may be important in the production of type I IFNs by cells in response to DNA viral challenge in a DNA-dependent RNA polymerase III manner ([@B1]; [@B16]). In the proposed model, AT-rich double-stranded DNA serves as a template for RNA polymerase III and is transcribed into RNA containing a 5′-triphosphate, the ligand for RIG-I. Subsequent activation of RIG-I by this ligand has been shown to induce type I IFN production and to activate NF-κB, and studies employing RNA polymerase III knockdown or pharmacological inhibitors of this enzyme have shown that this pathway is important in cell responses to the gammaherpesvirus Epstein-Barr virus ([@B1]; [@B16]). Together, these studies suggest that the transcription of cytosolic viral DNA by RNA polymerase III and subsequent RNA recognition by RIG-I could provide an additional mechanism by which glial cells perceive DNA viruses.

Interestingly, there has been a recent report of a role for the well-characterized bacterial sensor, NOD2, in the recognition of viral infections and the activation of IRF-3 via IPS-1 ([@B79]). While NOD2 is known to recognize the bacterial cell wall component muramyl dipeptide and trigger NF-κB activation via the adaptor molecule RIP2, [@B79] have provided evidence that this sensor is also important in the detection of ssRNA derived from respiratory syncytial virus. However, it is currently unknown if NOD2 is directly activated by this viral ligand, or is activated secondarily following association with other PRRs or RNA binding factors. Furthermore, it remains to be determined whether such interactions between NLRs and RIG-I-associated signaling components occur in glial cells or whether they play a significant role during viral CNS infections.

CONCLUDING REMARKS
==================

The importance of innate immunity in host responses to viral CNS infection is evident. Microglia and astrocytes express a diverse array of cell surface, endosomal, and cytosolic molecules that can serve as sensors for RNA and DNA viruses, either constitutively or following activation. It is also clear that resident CNS cells can respond to a diverse array of ligands and that exquisite control of the associated signaling pathways exists leading to the observed complexity in the interactions between the innate and adaptive arms of the host immune response. However, it is obvious that we still do not fully understand the precise nature and structure of the ligands for many of these PRRs or their mode of generation during infection. Furthermore, the available data suggest that models that ascribe discrete PRRs to each particular pathogen are overly simplistic. Rather, it appears that TLRs, RLRs, NLRs, and DAI function as PRRs and/or adaptor molecules that act in a cooperative/synergistic manner to promote glial responses to viral pathogens.

In addition to these caveats, it is almost certain that additional PRRs await discovery in glial cells and the nature of the interactions between these viral sensors and cellular activation pathways have yet to be determined. Finally, it is unclear whether and to what degree viral CNS pathogens evade detection or manipulate immune responses to their advantage. Answering these questions will lead to greater understanding of the fundamental mechanisms underlying glial activation by neurotropic viruses and will contribute significantly to our understanding of the events that underlie the development of either protective host responses or life threatening neuroinflammation.
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